Some notice minimal change initially as the body adjusts and doses are low
Medications like Wegovy and Zepbound have helped many people manage their weight, but the idea of giving yourself weekly injections can feel intimidating
Safety data across larger populations TRIUMPH-4 enrolled a specific population (obesity with knee osteoarthritis)
This is the chart that prevents every dose calculation error in your protocol
Stabilized analogs of both PP and PYY have undergone development, entering clinical trials as therapies for obesity
Diabetes Metab J 44(6):80218 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept